News | October 15, 2014

University of Iowa and IBA to Collaborate on Ultra-High Precision Proton Therapy

New system uses collimation to improve conformity of dose distributions to match target volume

October 15, 2014 — Ion Beam Applications SA (IBA) announced that the University of Iowa and IBA have signed a research collaboration agreement and a technology license agreement to develop ultra-high precision intensity modulated proton therapy (IMPT). This agreement includes an exclusive license on the Dynamic Collimation System (DCS) recently developed and presented by the University of Iowa at the American Association of Physicists in Medicine (AAPM) meeting in Austin, Texas.

The Dynamic Collimation System is a device developed by University of Iowa Carver College of Medicine faculty members to improve dose conformity in IMPT. The applications for the DCS could extend to many tumor sites and is expected to improve hypo-fractionated treatments in proton therapy on a five-year horizon.

Frédéric Genin, executive VP product development and management commented: "As soon as we saw the Dynamic Collimation System, we were amazed by its power and its simplicity. The team at University of Iowa impressed us by their creativity and by their approach to the possibilities of proton therapy. We are therefore delighted to partner with them on this project."

Daniel Hyer, Ph. D., proton therapy technical director and clinical assistant professor of radiation oncology, added: "Pencil beam scanning (PBS) provides the ability to magnetically shape dose distributions to match the target volume, but the conformity of these distributions can still be improved with the addition of collimation. Over the last two years, we have developed a novel device, called the Dynamic Collimation System, which is capable of providing layer-by-layer collimation. The DCS is also designed with a much smaller footprint than an MLC, allowing for a small air gap to maximize the benefits of collimation in proton therapy. We are excited to be working with IBA on this project to further improve proton therapy."

For more information: www.iba-worldwide.com; www.medicine.uiowa.edu

Related Content

MedStar Georgetown Conducts World's First Hyperscan Proton Therapy Treatment
News | Proton Therapy | April 27, 2018
For the first time, cancer patients in the Washington, D.C. metropolitan region have access to proton therapy, now...
First Patient Treated on Mevion's S250i Proton Therapy System
News | Proton Therapy | April 05, 2018
Mevion Medical Systems announced the treatment of the first patient in the world on the Mevion S250i Proton Therapy...
MEDraysintell released a report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.

MEDraysintell released a report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.

Feature | Proton Therapy | March 06, 2018 | By Jeff Zagoudis
Proton therapy has experienced major growth in the last decade, but that growth seems to have slowed slightly in recent...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
IBA Announces First Patient Treated with Proteus PLUS in The Netherlands
News | Proton Therapy | January 25, 2018
January 25, 2018 –  IBA (Ion Beam Applications SA) has announced that the University Medical Center Groningen (UMCG)
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
RaySearch Releases RayStation 7 Radiotherapy Treatment Planning System
Technology | Treatment Planning | December 19, 2017
RayStation 7, the latest release of RaySearch’s radiation therapy treatment planning system, adds new functionality and...
Baptist Hospital's Miami Cancer Institute Treats First Patient With Proteus Plus Proton Therapy
News | Proton Therapy | December 19, 2017
December 19, 2017 — IBA (Ion Beam Applications SA) announced that Miami Cancer Institute treated its first patients,
Overlay Init